MedDataX Logo

Anterior Segment Changes After Phacoemulsification in Cataractous Eyes with Shallow Anterior Chamber

NCT ID: NCT06745596

Last Updated: 2024-12-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-22

Study Completion Date

2024-06-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Phacoemulsification in shallow anterior chamber is considered to be more hazardous regarding risk of intraoperative and postoperative complications. Limited anterior pars plana vitrectomy can be combined with phacoemulsification to deepen the anterior chamber and facilitate surgical steps

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Phacoemulsification in shallow anterior chamber is considered to be more hazardous regarding risk of intraoperative and postoperative complications. Limited anterior pars plana vitrectomy can be combined with phacoemulsification to deepen the anterior chamber and facilitate surgical steps. This study aimed to compare the efficacy of combined phacoemulsification with limited pars plana vitrectomy versus phacoemulsification alone in cases with shallow anterior chamber.

Methods: 24 eyes were operated on and divided into two groups. Twelve eyes underwent combined approach and the other 12 eyes have undergone phacoemulsification only.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cataract

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Limited anterior pars plana vitrectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

24 eyes were operated on and divided into two groups. Twelve eyes underwent combined approach and the other 12 eyes have undergone phacoemulsification only
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cataract with limited anterior pars plana vitrectomy

group I included twelve patients who underwent phacoemulsification combined with limited anterior pars plana vitrectomy

Group Type ACTIVE_COMPARATOR

cataract surgery 1

Intervention Type PROCEDURE

Cataract with limited anterior pars plana vitrectomy

Cataract without limited anterior pars plana vitrectomy

group II included twelve patients that underwent phacoemulsification only

Group Type ACTIVE_COMPARATOR

cataract surgery 2

Intervention Type PROCEDURE

cataract without limited anterior pars plana vitrectomy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

cataract surgery 1

Cataract with limited anterior pars plana vitrectomy

Intervention Type PROCEDURE

cataract surgery 2

cataract without limited anterior pars plana vitrectomy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Anterior chamber depth of less than 2.8 mm associated with cataract

Exclusion Criteria

* Mature cataract
* History of previous ocular surgery
* Posterior segment pathology
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zagazig University

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mahmoud Mohammad Gamal Mohammad Gamal, MBBCh

Role: STUDY_DIRECTOR

Zagazig University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Zagazig University

Zagazig, Sharqia Province, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Zagazig university

Identifier Type: OTHER

Identifier Source: secondary_id

#467/24-June-2024.

Identifier Type: -

Identifier Source: org_study_id